Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of the Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With Allergic Rhinitis

NCT01880840 is registered in ClinicalTrials.gov with Meda Pharmaceuticals as lead sponsor.

NCT NCT01880840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01880840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of the Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With Allergic Rhinitis
Lead sponsor
Meda Pharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2013
Completion date
August 31, 2014
Enrollment
191 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis